STOCK TITAN

SpringWorks Therapeutics to Present at the Cowen 2nd Annual Oncology Innovation Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SpringWorks Therapeutics (Nasdaq: SWTX) announced its participation in a Fireside Chat at the Cowen 2nd Annual Oncology Innovation Summit on May 21, 2021, at 10:00 AM ET. The event aims to highlight the company’s efforts in developing medicines for rare diseases and cancer. Interested parties can access the live webcast through the company’s website, with a replay available afterward. SpringWorks is known for its precision medicine approach and is advancing clinical trials for targeted oncology product candidates.

Positive
  • None.
Negative
  • None.

STAMFORD, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Cowen 2nd Annual Oncology Innovation Summit on Friday, May 21st at 10:00AM ET.

To access the live webcast please visit the “Events & Presentations” page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the summit.

About SpringWorks Therapeutics

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio. For more information, visit www.springworkstx.com and follow @SpringWorksTx on Twitter and LinkedIn

Contact:
Kim Diamond
Phone: 203-561-1646
Email: kdiamond@springworkstx.com


FAQ

What is the date and time of the SpringWorks Therapeutics Fireside Chat?

The Fireside Chat will take place on May 21, 2021, at 10:00 AM ET.

How can I access the SpringWorks Therapeutics webcast?

You can access the live webcast by visiting the ‘Events & Presentations’ page in the Investors & Media section of the SpringWorks website.

What is the focus of SpringWorks Therapeutics?

SpringWorks Therapeutics focuses on developing life-changing medicines for patients with severe rare diseases and cancer.

What is the ticker symbol for SpringWorks Therapeutics?

The ticker symbol for SpringWorks Therapeutics is SWTX.

What event is SpringWorks Therapeutics participating in?

SpringWorks Therapeutics is participating in the Cowen 2nd Annual Oncology Innovation Summit.

SpringWorks Therapeutics, Inc.

NASDAQ:SWTX

SWTX Rankings

SWTX Latest News

SWTX Stock Data

2.57B
70.75M
1.92%
116.49%
16.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
STAMFORD